Humanin(CAS: 330936-69-1)

Humanin (CAS: 330936-69-1) is primarily regulated under REACH in the European Union, which requires manufacturers and importers to register substances above a certain tonnage. Additionally, it may be subject to FDA regulations in the United States for pharmaceutical applications. The compound is not classified as hazardous under GHS, but proper handling and storage practices should still be followed to ensure safety.

There are no direct alternatives to Humanin (CAS: 330936-69-1) in synthesis, as it is a unique peptide with specific biological activities. However, there are similar peptides or analogs that can be explored for similar applications. Common alternative reagents used in the synthesis of related peptides include Fmoc chemistry or solid-phase peptide synthesis methods.

The market for Humanin (CAS: 330936-69-1) is growing due to its potential in Alzheimer's disease and other neurodegenerative disorders. Research trends include further investigation into its mechanisms of action, development of more efficient synthesis methods, and exploration of its therapeutic applications in regenerative medicine.

Waste containing Humanin (CAS: 330936-69-1) should be collected in appropriate, leak-proof containers and disposed of through a professional waste disposal service specializing in chemical waste. Proper labeling is essential, and environmental protection measures should be taken to prevent contamination. Incineration is a common method for disposal, but it should be done in compliance with local regulations and guidelines.